COVID-19 (SARS CoV-2) nAb Rapid Diagnostic Test


SARS CoV-2 neutralizing antibodies (nAb) are specialized antibodies that block SARS CoV-2 from binding to our cells. SARS CoV-2 vaccines ultimately aim to incite growth of neutralizing antibodies to develop acquired immunity in patients. Optical Q SARS CoV-2 nAb detection kit is a breakthrough in-vitro (IVD) fluorescence immunoassay (FIA) point of care (POCT) solution that can quantitatively measure neutralizing antibodies of COVID-19 in blood samples within 15 minutes. This breakthrough reagent test kit will allow for: * Evaluating vaccine efficacy by detecting SARS-CoV-2 neutralizing antibodies in the serum/plasma from vaccinated patients; * Monitoring immunization by mass detecting SARS-CoV-2 neutralizing antibodies in serum/plasma of recovering COVID-19 patients.
0ptiBio Co., Ltd.OptiBio is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and manufacturing cutting edge fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach to immunoassay. OptiBio's competitive advantage stems from its strong foundation of experts, each specialized in fields crucial for product development. Our R&D is divided into 3 different teams of scientists and engineers dedicated to the independent development of diagnostic markers, test kits, and analyzers.  Our fundamental approach to in-house specialization allows OptiBio to constantly improve our product performance, customize our solutions based on client feedback, develop new test parameters, and respond to changing market needs. Shortly following the outbreak of Covid-19, for example, OptiBio quicky developed, without any outsourcing, the Optical Q SARS-CoV-2 neutralizing antibody (nAb) test kit and Rapid Q SARS-CoV-2 Antigen (Ag) rapid test kit.  OptiBio will continue to create, improve, and innovate world class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.  --------------------------------------------------------------------------- Optical Q, OptiBio's proprietary fluorescence immunoassay analyzer brand, currently features 25 test parameters. Please see below for details:  Inflammation: CRP, PCT                                                                                            Tumor: AFP, CEA, PSA                                                                                             Hormone: Beta-hCG, LH, FSH, Prolactin, Cortisol, Testosterone, Progesterone Thyroid: TSH, Total T3, Free T3, Total T4, Free T4                                               Cardiac: Myoglobin, CK-MB, D-dimer, NT-proBNP                                            Diabetes: HbA1c                                                                                                      Others: Ferritin                                                                                                         COVID-19: Neutralizaing antibody (nAb), Antigen (Ag)